Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review
Open Access
- 11 December 2023
- journal article
- review article
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 18, e31
Abstract
Percutaneous coronary intervention with stent implantation is an integral aspect of minimally interventional cardiac procedures. The technology and techniques behind stent design and implantation have evolved rapidly over several decades. However, continued discourse remains around optimal peri- and post-interventional management with dual antiplatelet therapy to minimise both major cardiovascular or cerebrovascular events and iatrogenic bleeding risk. Standard guidelines around dual antiplatelet therapy historically recommended long-term dual antiplatelet therapy for 12 months (with consideration for >12 months in certain patients); however, emerging data and generational improvements in the safety of drug-eluting stents have ushered in a new era of short-term therapy to reduce the incidence of major bleeding events. This case review will provide an overview of the current state of guidelines around duration of dual antiplatelet therapy and examine recent updates and continued gaps in existing research.Keywords
This publication has 75 references indexed in Scilit:
- Coronary stents: historical development, current status and future directionsBritish Medical Bulletin, 2013
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary StentingCirculation, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionJACC, 2011
- Stent: The Man and Word Behind the Coronary Metal ProsthesisCirculation: Cardiovascular Interventions, 2011
- Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial InfarctionCirculation, 2009
- Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of CardiologyEuropean Heart Journal, 2008
- A Cause for ConcernCirculation, 2007
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsNew England Journal of Medicine, 2006
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987